Blincyto (blinatumomab) - Amgen
Global development of bispecific antibodies in oncology: a bibliometric analysis of geographic disparities, collaborative models, and emerging translational strategies. (PubMed, Front Immunol) - Sep 5, 2026 - "This study reconstructs the global intellectual landscape and thematic evolution of oncology-oriented bsAb research. The findings provide a bibliometric overview of scientific development, identify current research frontiers, and may inform future collaboration, research prioritization, and investigation of next-generation bsAb therapies." 
Journal • Review • Hematological Disorders • Hematological Malignancies • Oncology • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42694423
 
Bingqi Dong; Dongning Yao; Lixia Fu; Xiaocong Pang; Xiaotian Zhai; Yanlun Gu; Yimin Cui; Zhuona Rong
 
Sep 5, 2026
 
Prev Next